ASCEND BY NTHRYS
Research Abroad Products

Gene Fusion Project Topics

Browse all focused areas across all project categories under this field.

Showing 121–132 of 200 project topics
Real-time BCR-ABL Mutation Detection SaaS Platform
A cloud-based diagnostic platform that sequences and identifies BCR-ABL fusion variants and resistance mutations in chronic myeloid leukemia patients within 48 hours. This enables oncologists to prescribe targeted tyrosine kinase inhibitors faster, reducing time-to-treatment and generating recurring subscription revenue from hospitals and diagnostic labs.
Leukemia Gene Fusion Analytics Platform Click to view more details →
Automated KMT2A Rearrangement Classification Engine
An AI-powered software tool that automatically detects and classifies KMT2A gene fusions in acute leukemia samples using whole genome sequencing data. This accelerates diagnostic workflows, reduces manual annotation costs by 70%, and generates licensing fees from clinical laboratories performing routine leukemia testing.
Leukemia Gene Fusion Analytics Platform Click to view more details →
RUNX1-RUNX1T1 Fusion Monitoring Web Dashboard
A commercial web-based dashboard that tracks minimal residual disease through quantitative RUNX1-RUNX1T1 fusion transcript monitoring across multiple patient timepoints. This enables leukemia clinics to optimize chemotherapy protocols and predict relapse risk, creating value-based licensing opportunities with cancer treatment centers.
Leukemia Gene Fusion Analytics Platform Click to view more details →
PML-RARA Acute Promyelocytic Leukemia Testing Service
A CLIA-certified molecular testing service offering rapid PML-RARA fusion detection and arsenic trioxide sensitivity profiling for acute promyelocytic leukemia patients. This high-margin service generates per-test revenue while improving patient outcomes through targeted arsenic and ATRA combination therapy optimization.
Leukemia Gene Fusion Analytics Platform Click to view more details →
TEL-AML1 Pediatric Leukemia Risk Stratification Tool
A predictive analytics platform that combines TEL-AML1 fusion detection with genome-wide copy number analysis to stratify pediatric ALL patients into risk groups. This enables clinical decision support for therapy intensification, generating recurring SaaS fees from pediatric oncology networks and children''s hospitals.
Leukemia Gene Fusion Analytics Platform Click to view more details →
Multi-Fusion Panel Next-Generation Sequencing Assay
A commercial targeted NGS panel detecting 50+ leukemia-defining gene fusions including ABL1, MLL, CBFB, and ETV6 variants in a single workflow. This premium diagnostic service commands higher reimbursement rates while reducing per-sample turnaround time, maximizing laboratory throughput and profitability.
Leukemia Gene Fusion Analytics Platform Click to view more details →
CBFB-MYH11 Fusion Digital Pathology Integration Platform
A cloud software solution that integrates CBFB-MYH11 fusion molecular results with digital pathology images and clinical data for comprehensive acute myeloid leukemia reporting. This creates a unified diagnostic product that increases clinical utility, improves customer retention, and enables white-label partnerships with larger diagnostic companies.
Leukemia Gene Fusion Analytics Platform Click to view more details →
EWSR1-FLI1 Gene Fusion Commercial Reference Laboratory Network
A federated network of CLIA labs offering EWSR1-FLI1 and related fusion testing with standardized quality metrics and rapid turnaround for Ewing sarcoma and other sarcomas. This B2B service model generates high-volume referral revenue while establishing market dominance in specialized sarcoma diagnostics.
Leukemia Gene Fusion Analytics Platform Click to view more details →
NUP98 Fusion Variant Interpretation Clinical Decision Support
An enterprise clinical informatics platform that interprets NUP98 fusion variants and recommends targeted therapies, including experimental drugs and clinical trials, based on fusion type. This premium decision support tool generates usage-based licensing revenue from academic medical centers and integrated delivery networks.
Leukemia Gene Fusion Analytics Platform Click to view more details →
Fusion Gene Therapy Matching and Patient Registry Database
A proprietary patient registry and matching platform that connects leukemia patients with specific gene fusions to eligible CAR-T, targeted gene therapy, and clinical trial opportunities. This B2B2C platform generates revenue from pharmaceutical sponsors seeking qualified patient populations and from patient data licensing agreements.
Leukemia Gene Fusion Analytics Platform Click to view more details →
Real-Time Gene Fusion Detection SaaS Platform
A cloud-based SaaS platform that processes sequencing data to identify and classify gene fusions in solid tumors within hours of sample receipt. Enables clinical labs to monetize rapid turnaround reporting and support precision oncology treatment decisions for payers and hospital networks.
Solid Tumor Gene Fusion Analytics Dev Click to view more details →
AI-Powered Fusion Variant Interpretation Engine
A machine learning software tool that automatically predicts oncogenic potential, drug sensitivity, and clinical actionability of detected gene fusions in real time. Generates recurring SaaS revenue through subscription licensing while reducing manual curation costs and accelerating time-to-report.
Solid Tumor Gene Fusion Analytics Dev Click to view more details →